C-reactive protein, inflammation, and coronary risk

被引:128
作者
Morrow, DA
Ridker, PM
机构
[1] Brigham & Womens Hosp, Div Cardiovasc, Dept Med, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Prevent Med, Dept Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
关键词
D O I
10.1016/S0025-7125(05)70211-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Data have revealed interactions between baseline concentration of hs-CRP and the efficacy of common pharmacologic therapies in primary and secondary prevention, suggesting not only that it may be possible to modify the increased risk associated with elevated hs-CRP, but also that inflammatory markers may be useful in targeting preventive therapies, inflammatory markers may become a valuable component of routine cardiovascular risk assessment.
引用
收藏
页码:149 / +
页数:14
相关论文
共 85 条
  • [1] ANGIOGRAPHIC MORPHOLOGY AND THE PATHOGENESIS OF UNSTABLE ANGINA-PECTORIS
    AMBROSE, JA
    WINTERS, SL
    STERN, A
    ENG, A
    TEICHHOLZ, LE
    GORLIN, R
    FUSTER, V
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (03) : 609 - 616
  • [2] CYTOKINES AND GROWTH-FACTORS POSITIVELY AND NEGATIVELY REGULATE INTERSTITIAL COLLAGEN GENE-EXPRESSION IN HUMAN VASCULAR SMOOTH-MUSCLE CELLS
    AMENTO, EP
    EHSANI, N
    PALMER, H
    LIBBY, P
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (05): : 1223 - 1230
  • [3] MONOCYTIC ORIGIN OF FOAM CELLS IN HUMAN ATHEROSCLEROTIC PLAQUES
    AQEL, NM
    BALL, RY
    WALDMANN, H
    MITCHINSON, MJ
    [J]. ATHEROSCLEROSIS, 1984, 53 (03) : 265 - 271
  • [4] ELEVATION OF C-REACTIVE PROTEIN IN ACTIVE CORONARY-ARTERY DISEASE
    BERK, BC
    WEINTRAUB, WS
    ALEXANDER, RW
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (03) : 168 - 172
  • [5] Elevated levels of interleukin-6 in unstable angina
    Biasucci, LM
    Vitelli, A
    Liuzzo, G
    Altamura, S
    Caligiuri, G
    Monaco, C
    Rebuzzi, AG
    Ciliberto, G
    Maseri, A
    [J]. CIRCULATION, 1996, 94 (05) : 874 - 877
  • [6] IDENTIFICATION AND DISTRIBUTION OF FIBRINOGEN, FIBRIN, AND FIBRIN(OGEN) DEGRADATION PRODUCTS IN ATHEROSCLEROSIS - USE OF MONOCLONAL-ANTIBODIES
    BINI, A
    FENOGLIO, JJ
    MESATEJADA, R
    KUDRYK, B
    KAPLAN, KL
    [J]. ARTERIOSCLEROSIS, 1989, 9 (01): : 109 - 121
  • [7] Boyle JJ, 1997, J PATHOL, V181, P93, DOI 10.1002/(SICI)1096-9896(199701)181:1<93::AID-PATH696>3.0.CO
  • [8] 2-H
  • [9] PLAQUE FISSURES IN HUMAN CORONARY THROMBOSIS
    CONSTANT.P
    [J]. JOURNAL OF ATHEROSCLEROSIS RESEARCH, 1966, 6 (01): : 1 - &
  • [10] Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
    Corsini, A
    Bernini, F
    Quarato, P
    Donetti, E
    Bellosta, S
    Fumagalli, R
    Paoletti, R
    Soma, VMR
    [J]. CARDIOLOGY, 1996, 87 (06) : 458 - 468